PhD in reproductive tox, worked in pre-clinical pharma for 25 years in Hit ID, Hits to Lead, Target Biology sections developing cell based assays for compound screening. Founding entrepreneur of Aurelia Bioscience in 2012, delivering tailored assay development for compounds pharmacological profiling for screening purposes